Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities:    
Consolidated net income $ 625.5 $ 448.6
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 354.9 295.2
Stock-based compensation expense 44.8 43.9
Deferred income taxes 12.6 82.2
Loss (gain) on fair market value adjustment of equity investments 0.1 (162.8)
Gain on divestiture (0.2) 0.0
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (54.9) (76.1)
Other assets, current and long-term 5.1 29.6
Current and long term liabilities, excluding debt (38.4) (11.6)
Cash provided by operating activities 949.5 649.0
Investing activities:    
Capital expenditures (332.9) (309.5)
Acquisitions, net of cash acquired (1,108.9) (61.4)
Cash received from divestiture 1.5 0.0
Investment in unconsolidated affiliates, net 0.0 (10.0)
Cash used in investing activities (1,440.3) (380.9)
Financing activities:    
Net short-term borrowings 499.2 0.3
Payments on long-term debt (1,100.2) (125.0)
Borrowings on long-term debt 1,697.3 1,123.3
Treasury stock purchases (69.9) 0.0
Dividends paid to Equifax shareholders (142.6) (142.1)
Dividends paid to noncontrolling interests (6.5) (2.6)
Proceeds from exercise of stock options and employee stock purchase plan 33.4 29.9
Payment of taxes related to settlement of equity awards (43.9) 0.0
Purchase of noncontrolling interests (11.2) (9.0)
Debt issuance costs (13.2) (9.8)
Other 0.0 0.3
Cash provided by financing activities 842.4 865.3
Effect of foreign currency exchange rates on cash and cash equivalents (10.7) 0.9
Increase in cash and cash equivalents 340.9 1,134.3
Cash and cash equivalents, beginning of period 1,684.6 401.3
Cash and cash equivalents, end of period $ 2,025.5 $ 1,535.6